2006 - Drug Discovery Digest

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

FDA Law Blog: Drug Discovery

MARCH 7, 2024

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.

Clinical Trials

Clinical Trials Trials FDA Regulations

Deep Brain Stimulation Helps Two Patients Walk After Spinal Cord Injury

Drugs.com

DECEMBER 3, 2024

3, 2024 -- In 2006, Wolfgang Jäger was in his 30s when a skiing accident left the young Austrian wheelchair-bound from a spinal cord injury.Fast-forward to today, where an innovative deep-brain stimulation technique is helping the. TUESDAY, Dec.

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels

MARCH 28, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights. All rights reserved.

Marketing

Marketing Science Therapies Production

Young Workers' Injuries Rise After Recreational Marijuana Sales Made Legal

Drugs.com

FEBRUARY 23, 2024

Bureau of Labor statistics for 2006 through 2020 show that legal “recreational marijuana. FRIDAY, Feb. 23, 2024 -- After states legalize the sale of weed for recreational use, on-the-job injuries rise among younger workers, new research shows.U.S.

Research

Four Keys to Success for Retail and Specialty-Lite Hub Services

Drug Channels

FEBRUARY 23, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She outlines four success factors for manufacturers that use a digital hub partner. To learn more, register for Phil's upcoming webinar: Improving Access, Coverage, and GTN with a Digital Hub. Read on for Nicole’s insights.

Drugs

New Survey Reveals Manufacturers’ Patient Services Priorities for 2024

Drug Channels

FEBRUARY 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. As he explains, manufacturers want hub partners that can take a holistic approach and address each patient’s individual needs. Nasir also discusses how hub selection criteria are evolving. Read on for Nasir’s insights. All rights reserved.

Production

Production Research Drugs

Copay Comes Full Circle: An Industry Ready for Disruption

Drug Channels

MARCH 8, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To request an analysis of your copay savings program and learn more about Paysign’s patient affordability solutions, contact affordability@paysign.com or visit paysign.com/rx. Read on for Logan’s insights. All rights reserved.

Drugs

At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs

Drug Channels

JULY 12, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, register for Kalderos’ August 21, 2024, webinar: Revolutionizing Government Discount Programs: Why Traditional Methods Fail. Read on for Gavin’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Government

Government Drugs

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

APRIL 12, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more about enhancing patient engagement and adherence, download CareMetx's new report: Driving Brand Success: Minimize Risk and Capture Missed Value from Patient Engagement and Adherence. Read on for Jessica’s insights.

Drugs

Three Digital Intake Strategies For Eliminating Patient Enrollment Forms

Drug Channels

MARCH 22, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He then explains three ways that specialty pharmaceutical companies can use digital intake strategies to speed patient enrollment. Read on for Adam’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Pharmaceutical Companies

Pharmaceutical Companies Therapies Pharmaceuticals Drugs

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

APRIL 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. All rights reserved.

Pharmacy

Pharmacy Marketing Drugs

New Report: How GoodRx Improves the Economics of Healthcare

Drug Channels

FEBRUARY 2, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. She highlights how GoodRx’s integrated pharma copay cards help to improve medication access, therapy adherence, and overall health outcomes. Read on for Divya’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Therapies

Therapies Marketing Research Drugs

The Four Key Factors to Evaluate When Insourcing vs. Outsourcing Patient Support Programs

Drug Channels

MARCH 15, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He shares data from a Cardinal Health survey of biopharmaceutical companies and offers four factors to consider when evaluating your patient support program. Read on for Josh’s insights. All rights reserved.

Drugs

The Drug Discount Ecosystem Needs Clarity in 2024 and Beyond

Drug Channels

FEBRUARY 16, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Gavin’s insights. All rights reserved. This Feed is for personal non-commercial use only.

Drugs

Solving Access Barriers in Biomarker Testing: 5 Tips for Manufacturers

Drug Channels

MAY 9, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. They discuss five ways manufacturers can prevent these barriers from affecting patients. To learn more about navigating the complexities of market access, contact MMIT and its sister company, The Dedham Group. Read on for their insights.

Therapies

Therapies Marketing Drugs

Innovative Models for Improving Access and Visibility for Specialty-Lite and Retail Therapies

Drug Channels

OCTOBER 4, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, register for AssistRx's free webinar on October 8: Meet Your Patients Where They Are & Gain Visibility: Even at Retail. Read on for Timothy’s insights. All rights reserved.

Therapies

Therapies Production Drugs

Bracing for Impact: The Future of Hub, PAP, and Affordability Programs Under the Inflation Reduction Act

Drug Channels

MAY 2, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. To learn more, join Chris on May 21 at 1:00 p.m. ET for a free online panel discussion about how brands can continue to offer robust patient support despite IRA challenges. Read on for Chris’ insights. All rights reserved.

Marketing

Marketing Drugs

The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access

Drug Channels

OCTOBER 17, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. They argue that a technology-enabled infrastructure, combined with clinical and reimbursement support specialists, can improve patients' access to new therapies, shorten the time to therapy, and enable better overall clinical outcomes.

Therapies

Therapies Drugs

Can Rite Aid Recover?

Drug Channels

AUGUST 13, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Drug Channels has been tracking retail pharmacies’ economic and business challenges —and Rite Aid’s troubles—for many years. Consider this article to be an opportunity for some fact-based analysis to replace your schadenfreude.

Pharmacy

Pharmacy Drugs

Breaking Down Barriers: Helping Patients Get Therapies Quickly

Drug Channels

APRIL 26, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Meet CoverMyMeds in Booth 1305 at the Asembia AXS24 Summit. To keep up with CoverMyMeds and all the action at Asembia, click here to sign up for daily recaps from Asembia. Read on for Kevin’s insights. All rights reserved.

Therapies

Therapies Drugs

Exclusive Report: Manufacturers Identify the Three Critical Drivers of Hub Success

Drug Channels

FEBRUARY 24, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Matt shares three key findings from CareMetx’s exclusive new survey on patient support services for specialty pharmaceuticals. To learn more, download CareMetx’s free 2022 Report - Patient Services Trends. Read on for Matt’s insights. d/b/a Drug Channels Institute.

Pharmaceuticals

Pharmaceuticals Drugs

What Pharma Companies Can Expect From the Influx of Humira Biosimilars

Drug Channels

OCTOBER 14, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Steve walks us through the expected Humira biosimilars launches and discusses potential responses from payers. To learn more, check out MMIT’s Strategic Launch Report & Evaluate Forecast solution. Read on for Steve’s insights. d/b/a Drug Channels Institute.

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents

Drug Channels

APRIL 16, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Alas, specialty pharmacies owned by the three largest pharmacy benefit managers (PBMs) have the most brass in their pocket, as they accounted for two-thirds of prescription revenues from pharmacy-dispensed specialty drugs. All rights reserved.

Specialty Pharmacies

Specialty Pharmacies Pharmacy Marketing Hospitals

A New Point-of-Prescribing Solution to Help Increase Prescribing Accuracy, Speed to Therapy and Patient Adherence

Drug Channels

JANUARY 13, 2023

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. He describes CoverMyMeds’ provider alerts solution, which is designed to minimize medication errors. Click here to learn more about CoverMyMeds’ Provider Medication Alerts solution. Read on for Clay’s insights. d/b/a Drug Channels Institute.

Therapies

Therapies Production Drugs

Improve Access, Affordability, and Brand Performance With GoodRx’s Point-of-Sale Rebate Programs

Drug Channels

FEBRUARY 17, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Jim discusses GoodRx Assist , a point-of-sale (POS) rebate program designed to help cash-paying patients start and stay on brand-name medication. Click here to learn more about GoodRx Assist. Read on for Jim’s insights. d/b/a Drug Channels Institute.

Drugs

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2024 Update

Drug Channels

MAY 7, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. The companies face renewed scrutiny from the Federal Trade Commission, the Office of Inspector General, and members of Congress. All rights reserved. This Feed is for personal non-commercial use only.

Specialty Pharmacies

Specialty Pharmacies Pharmacy Drugs

Another IRA Surprise: Part B Coinsurance Inflation Adjustments Are Increasing Patient Costs

Drug Channels

MAY 14, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Chalk off these coinsurance surprises to yet another unintended consequence of the IRA. Seniors who are expecting to see costs drop may find they are instead being taken for a rollercoaster ride. All rights reserved.

Drugs

What Manufacturers Need to Know About Alternative Payment Models

Drug Channels

JULY 15, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Carolyn explains the advantages of alternative payment models (APM) for measuring and rewarding value and outcomes in our healthcare system. For more on how APMs measure value, click here to learn about MMIT’s Pulse Analytics Solution. Read on for Carolyn’s insights.

Drugs

Building New Data Connections Helps Brands Lower Adherence

Drug Channels

OCTOBER 1, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Click here to learn about the ConnectiveRx Enterprise Data Platform. Read on for Kylie’s insights.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceuticals Production Drugs

The New Hub Features Improving Patient Assistance

Drug Channels

JULY 22, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Ian shares an overview of The Evolving Role of Hubs and Patient Services , his recent presentation at Informa Connect's Hub and Specialty Model East conference in June. Click here to watch Ian’s full presentation. Read on for Ian’s insights. d/b/a Drug Channels Institute.

Drugs

Optimizing Access: Balancing Speed-to-Therapy and Gross-to-Net

Drug Channels

JULY 7, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Sahil discusses how manufacturers can balance patients’ access to therapy with gross-to-net (GTN) goals. Visit [link] to learn more about how Phil helps improve the patient experience while managing GTN. Read on for Sahil’s insights. d/b/a Drug Channels Institute.

Therapies

Therapies Drugs

The Evolution of Medical Benefit Contracting: How Pharma Can Prepare

Drug Channels

JANUARY 27, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. He then describes how to automate formulary and medical policies to protect manufacturers from overpayment. Click here to learn about MMIT’s Contract Validation solution. Read on for Saket’s insights. d/b/a Drug Channels Institute.

What a Technology-First Approach Really Means for Your Patient Support Program

Drug Channels

MARCH 3, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. To learn more, download AssistRx's free 61-page eBook: Specialty Drug Patient Support Programs: 2022 Progress Report. Read on for Jan’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Therapies

Therapies Drugs

What Pharmaceutical Manufacturers Value Most from a Hub

Drug Channels

SEPTEMBER 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Based on CareMetx research, he outlines the key factors that drug manufacturers value in their hub partners. Learn more by downloading CareMetx’s full report: The Evolving Landscape of Digital Healthcare Hubs. Read on for Nasir’s insights. d/b/a Drug Channels Institute.

Pharmaceuticals

Pharmaceuticals Therapies Production Drugs

Cell and Gene Therapy Roundup: What the Road to Success Looks Like

Drug Channels

NOVEMBER 11, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about AmerisourceBergen’s Cell and Gene Therapy solutions for biopharma companies, providers, and patients. Read on for Lung-I’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Therapies

Therapies Drugs

Technology’s New Approach: One Gateway to Deliver Comprehensive Patient Support Services

Drug Channels

JUNE 16, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. He then discusses Advanced Gateway, a technology that integrates patient, provider, and manufacturer services. Click here to learn more about how AssistRx’s Advanced Gateway can impact patient support programs. Read on for Derek’s insights. d/b/a Drug Channels Institute.

Engineering

Engineering Drugs

Transforming Medication Access with the Next Generation of Patient Support Services

Drug Channels

DECEMBER 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. She describes how CoverMyMeds improves the patient experience by blending technology with human expertise and connection. Click here to learn about CoverMyMed’s next-generation patient support services. Read on for Kelly’s insights. d/b/a Drug Channels Institute.

Therapies

Therapies Production Drugs

The Pulse of Electronic Benefit Verification Solutions: Know the Facts

Drug Channels

SEPTEMBER 16, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. He also describes the circumstances where each solution provides the greatest value. To learn more, download AssistRx’s free eBook: Specialty Drug Patient Support Programs: 2022 Progress Report. Read on for Edward’s insights. d/b/a Drug Channels Institute.

Drugs

GoodRx Pharma Manufacturer Solutions: Partnering for Patient Access and Affordability

Drug Channels

JULY 7, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. He describes how GoodRx leverages its consumer reach to help biopharma companies boost awareness and utilization of manufacturers’ copay assistance programs. Click here to learn more about GoodRx’s patient awareness, access, and adherence solutions. Read on for Akeel’s insights.

Drugs

The Next Great Healthcare Surge: A ‘Diagnosis Explosion’

Drug Channels

AUGUST 19, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. He goes on to describe how human contact and support helps patients understand their disease and their treatment plan, thus increasing adherence. Click here to learn how CoverMyMeds’ technology interventions help patients. Read on for John’s insights. d/b/a Drug Channels Institute.

Treatment

Treatment Disease Drugs

Innovation Brings Unwavering Patient Support in a New Era of Specialty Medicine

Drug Channels

OCTOBER 21, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Learn more about CoverMyMeds’ patient-centric technology solutions by downloading their Access Report: Oncology Edition. Read on for Megan’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies

Specialty Pharmacies Pharmacy Drugs

Digital Transformation: Facilitating Healthcare Provider and Patient Behavior Change

Drug Channels

APRIL 14, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. To learn about AssistRx’s technology-first solutions, click here to schedule a meeting at Asembia’s Specialty Pharmacy Summit. Read on for Edward’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies

Specialty Pharmacies Pharmacy Therapies Drugs

Patients At Risk As Healthcare Navigates Affordability

Drug Channels

SEPTEMBER 9, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. To learn more about CoverMyMeds’ comprehensive affordability solutions, download Overcoming Medication Affordability Challenges with Patient-Centered Solutions. Read on for Kristina’s insights. d/b/a Drug Channels Institute. This Feed is for personal non-commercial use only.

Production

Production Drugs

Helping Patients Ease Medication-Affordability Anxiety

Drug Channels

JUNE 9, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Kristina then explains how manufacturers can increase patient access and affordability with a comprehensive affordability strategy. Click here to learn about CoverMyMeds’ medication access solutions for pharma. Read on for Kristina’s insights. d/b/a Drug Channels Institute.

Pharmacy

Pharmacy Production Drugs

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

Deep Brain Stimulation Helps Two Patients Walk After Spinal Cord Injury

Trending Sources

Navigating Market Access Challenges in Life Sciences Commercialization

Young Workers' Injuries Rise After Recreational Marijuana Sales Made Legal

Four Keys to Success for Retail and Specialty-Lite Hub Services

New Survey Reveals Manufacturers’ Patient Services Priorities for 2024

Copay Comes Full Circle: An Industry Ready for Disruption

At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs

How Patient Engagement Can Reduce Brand Launch Risks

Three Digital Intake Strategies For Eliminating Patient Enrollment Forms

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

New Report: How GoodRx Improves the Economics of Healthcare

The Four Key Factors to Evaluate When Insourcing vs. Outsourcing Patient Support Programs

The Drug Discount Ecosystem Needs Clarity in 2024 and Beyond

Solving Access Barriers in Biomarker Testing: 5 Tips for Manufacturers

Innovative Models for Improving Access and Visibility for Specialty-Lite and Retail Therapies

Bracing for Impact: The Future of Hub, PAP, and Affordability Programs Under the Inflation Reduction Act

The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access

Can Rite Aid Recover?

Breaking Down Barriers: Helping Patients Get Therapies Quickly

Exclusive Report: Manufacturers Identify the Three Critical Drivers of Hub Success

What Pharma Companies Can Expect From the Influx of Humira Biosimilars

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents

A New Point-of-Prescribing Solution to Help Increase Prescribing Accuracy, Speed to Therapy and Patient Adherence

Improve Access, Affordability, and Brand Performance With GoodRx’s Point-of-Sale Rebate Programs

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2024 Update

Another IRA Surprise: Part B Coinsurance Inflation Adjustments Are Increasing Patient Costs

What Manufacturers Need to Know About Alternative Payment Models

Building New Data Connections Helps Brands Lower Adherence

The New Hub Features Improving Patient Assistance

Optimizing Access: Balancing Speed-to-Therapy and Gross-to-Net

The Evolution of Medical Benefit Contracting: How Pharma Can Prepare

What a Technology-First Approach Really Means for Your Patient Support Program

What Pharmaceutical Manufacturers Value Most from a Hub

Cell and Gene Therapy Roundup: What the Road to Success Looks Like

Technology’s New Approach: One Gateway to Deliver Comprehensive Patient Support Services

Transforming Medication Access with the Next Generation of Patient Support Services

The Pulse of Electronic Benefit Verification Solutions: Know the Facts

GoodRx Pharma Manufacturer Solutions: Partnering for Patient Access and Affordability

The Next Great Healthcare Surge: A ‘Diagnosis Explosion’

Innovation Brings Unwavering Patient Support in a New Era of Specialty Medicine

Digital Transformation: Facilitating Healthcare Provider and Patient Behavior Change

Patients At Risk As Healthcare Navigates Affordability

Helping Patients Ease Medication-Affordability Anxiety

Stay Connected